Financial News

Financial Report: Syneos Health

inVentiv merger boosts revenues

By: Kristin Brooks

Managing Editor, Contract Pharma

Syneos Health
1Q Revenues: $1.06 billion (revenues were $252.1 million 1Q17)
1Q Loss: $24.6 million (earnings were $21.2 million 1Q17)
Comments: Revenue increase was primarily due to the Merger with inVentiv in August 2017. Under ASC 605, the Combined Company Clinical Solutions segment generated $530.9 million of adjusted service revenue in the quarter, up 2%.The Combined Company Commercial Solutions segment generated $230.6 million of adjusted service revenue, down 14% primarily due to project cancellations and customer downsizing within the company’s selling solutions and communications service offerings, along with lower new business awards in 2017 that reduced 2018 revenue.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters